Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HALO

HALOZYME THERAPEUTICS, INC.

CIK 0001159036 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$78.62
↓ 1.75 (-2.18%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals, Options

Key stats

Market Cap
$9.33B
P/E Ratio
26.73
EPS
2.64
Dividend Yield
Not covered
52W Position
86%
Beta
0.60

Valuation multiples

Fwd P/E
11.00
PEG
-2.50
P/B
42.46
P/S
6.18
EV/Revenue
7.40
ROE
158.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 86%
$55.64$82.26

Latest Financials

2025-12-31 FY
Revenue
$1.40B
Net Income
$316.89M
Total Assets
$2.53B
Free Cash Flow
$644.59M

Recent news